Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

medical product Latest News

  + XML/RSS  



By MediPurpose™
Introduced in 1999 as the SurgiLance One-Step safety lancet, MediPurpose’s flagship medical product has sold steadily since its launch.

By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application

By MediPurpose™
New Case Study Validates MediPlus Advanced Wound Care Product Positioning and Clinical Usage

By MediPurpose™
Clinical Use Studies Also Show 94-Percent Score for Ease-of-Use, Ergonomics and Performance Tests

By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada

By MediPurpose™
Case Studies Compared Alginate, Hydrocolloid, Film, Foam, and Surgical Dressings

By MediPurpose Pte.
Recertification Validates MediPurpose’s Medical Product Quality Management System (QMS)

By MediPurpose™
Results From Simulated and Clinical Use Survey at Citrus Valley Medical Center

By MediPurpose™
Amware will facilitate U.S. distribution of MediPurpose’s three medical products: babyLance™ infant heel incision devices, SurgiLance™ safety lancets, and MediPlus™ Advanced Wound Care products.

By MediPurpose™
Study Completes Two-Year Redesign Phase, Enabling Launch of New Neonatal Medical Device

By MediPurpose™
Second Singapore Patent Expands International Medical Device Intellectual Property Protection for babyLance

By MediPurpose™
Input From Neonatal Nurses Carefully Integrated Into Design Specifications for New Infant Heelstick Device

By MediPurpose™
New babyLance Heelstick Design Exceeds Benchmarks for Safety, Ergonomics

By MediPurpose®
Joins Kentec Medical and KOL Bio-Medical Instruments as Exclusive Regional Distributors in Western and Eastern United States

By MediPurpose®
Results Indicate New babyLance(r) Delivers an Ideal Incision

By MediPurpose®
Follows Recent White Paper That Described a Heelstick Trigger Activation Survey to Support Company's Redesign of babyLance Infant Heel Incision Device

By MediPurpose®
The white paper's key findings indicate a majority preference for a new design's pull trigger, validating the company's decision to move forward with a redesign of its heelstick device.

By MediPurpose®
MediPurpose(r), a medical product master distributor and manufacturer, today announced that the Centers for Medicare and Medicaid Services (CMS) has confirmed HCPCS reimbursement codes for its MediPlus(tm) Alginate wound dressings.

By MediPurpose
Expands Relationship for MediPurpose's Medical Product Distribution in Austria

By MediPurpose®
Safety Fingerstick Devices to be Used for Glucose and A1c Monitoring of New Orleans Diabetics

All Press Releases

By MediPurpose™
Introduced in 1999 as the SurgiLance One-Step safety lancet, MediPurpose’s flagship medical product has sold steadily since its launch.

By MediPurpose™
Analyzes End-Users Expectations, Clinical Studies, and FDA Guidance Documents and 510(k) with Sharps Safety Indication Application

By MediPurpose™
New Case Study Validates MediPlus Advanced Wound Care Product Positioning and Clinical Usage

By MediPurpose™
Clinical Use Studies Also Show 94-Percent Score for Ease-of-Use, Ergonomics and Performance Tests

By MediPurpose™
Authorizes Medical Product Company to Continue Distributing babyLance™ Safety Heelsticks and SurgiLance™ Safety Lancets in Canada

By MediPurpose™
Case Studies Compared Alginate, Hydrocolloid, Film, Foam, and Surgical Dressings

By MediPurpose Pte.
Recertification Validates MediPurpose’s Medical Product Quality Management System (QMS)

By MediPurpose™
Results From Simulated and Clinical Use Survey at Citrus Valley Medical Center

By MediPurpose™
Amware will facilitate U.S. distribution of MediPurpose’s three medical products: babyLance™ infant heel incision devices, SurgiLance™ safety lancets, and MediPlus™ Advanced Wound Care products.

By MediPurpose™
Study Completes Two-Year Redesign Phase, Enabling Launch of New Neonatal Medical Device

By MediPurpose™
Second Singapore Patent Expands International Medical Device Intellectual Property Protection for babyLance

By MediPurpose™
Input From Neonatal Nurses Carefully Integrated Into Design Specifications for New Infant Heelstick Device

By MediPurpose™
Redesigned Infant Heelstick Device Draws Enthusiasm From Neonatal Nurses

By MediPurpose™
New babyLance Heelstick Design Exceeds Benchmarks for Safety, Ergonomics

By MediPurpose®
Joins Kentec Medical and KOL Bio-Medical Instruments as Exclusive Regional Distributors in Western and Eastern United States

By MediPurpose®
Results Indicate New babyLance(r) Delivers an Ideal Incision

By MediPurpose®
Follows Recent White Paper That Described a Heelstick Trigger Activation Survey to Support Company's Redesign of babyLance Infant Heel Incision Device

By MediPurpose®
The white paper's key findings indicate a majority preference for a new design's pull trigger, validating the company's decision to move forward with a redesign of its heelstick device.

By MediPurpose®
MediPurpose(r), a medical product master distributor and manufacturer, today announced that the Centers for Medicare and Medicaid Services (CMS) has confirmed HCPCS reimbursement codes for its MediPlus(tm) Alginate wound dressings.

By MediPurpose
Expands Relationship for MediPurpose's Medical Product Distribution in Austria

By MediPurpose®
Safety Fingerstick Devices to be Used for Glucose and A1c Monitoring of New Orleans Diabetics

By MediPurpose®
The medical device company was recently notified that the Taiwan Intellectual Property Office approved MediPurpose's application to register a trademark, collective mark or certification mark in Taiwan for MediPlus.

By MediPurpose®
Johnson Brings More Than Two Decades of Medical Product Marketing Experience to Advanced Wound Care Product Division

By Derek Rudnak | MediPurpose®
Safety Fingerstick Devices Used for Diabetes Screenings of Patients

By Derek Rudnak | MediPurpose®
Continues Recent Expansion of MediPlus' Comprehensive Wound Care Product Portfolio

By Derek Rudnak | MediPurpose®
Trademark registration with the Intellectual Property Corporation of Malaysia protects both the word “MediPurpose” and the medical product company’s unique black and red logo.

By Derek Rudnak
Brings More Than Three Decades of Experience to Orange County Medical Product Design and Development Company

By Derek Rudnak | MediPurpose®
Seasoned Medical Device Engineer Brings More Than 30 Years of Expertise to Medical Product Company

By Derek Rudnak | MediPurpose®
The Announcement is the Second Tranche of HCPCS Codes for MediPurpose's Expanding Family of Advanced Wound Care Products

By Derek Rudnak | MediPurpose®
Fingerstick Device's Ease of Use, Safety and Price Among Key Factors

By Derek Rudnak
Leverages DeviceLab's Expertise in Medical Product Design, Engineering, Prototyping and Manufacturing for POC Diagnostics

By Derek Rudnak | MediPurpose®
MediPurpose Welcomes CLIAwaived Into POC Diagnostics Network

By Derek Rudnak | MediPurpose
The medical product company contributed 700 SurgiLance safety lancets to a team of nurses and pharmacists from St. John Fisher College that traveled to Pune, India to provide needed healthcare services.

By Derek Rudnak | MediPurpose®
Migration to Open Source CMS Supports Medical Device Company's Commitment to Innovation

By Derek Rudnak | MediPurpose®
The Medical Device's Trademark is Also Registered in the United States, China, South Korea, Singapore and Switzerland

By Derek Rudnak | MediPurpose®
EKF's Point-of-Care Tests to Continue Using SurgiLance Safety Lancets

By Derek Rudnak | MediPurpose
Medical Product Company Also Bids Farewell to President/CSO Randy Prather

By Derek Rudnak | MediPurpose®
New Silver Products Add to Extensive Line of Wound Dressings

By Derek Rudnak | MediPurpose®
More Than 100 Screened for Diabetes at SW Florida Health Fair

By Derek Rudnak | MediPurpose®
SurgiLance Safety Lancets to be Used in Type 2 Diabetes Screening

By Derek Rudnak | MediPurpose®
Independent Sales Network to Foster Growth of New MediPlus Advanced Wound Care Line

By Derek Rudnak | MediPurpose®
Quality, Ease of Use and Packaging Among Key Features to Yield Positive Responses

By Derek Rudnak | MediPurpose®
Medical Product Manufacturer Honored for Contributions to Successful Launch of New MediPlus Advanced Wound Care Product Line

By Derek Rudnak | MediPurpose®
The Medical Device's Trademark is Also Registered in the United States, Australia, China, South Korea, Singapore and Switzerland

By Derek Rudnak | MediPurpose®
Revisions Motivated by New GTIN Standards, U.S. FDA 510(k) Clearance, and Emerging International Demand

By Derek Rudnak | MediPurpose®
Medipurpose Conducted the Survey to Further Validate Its Extensive Research About 28-Gauge Safety Lancet Market Requirements

By Derek Rudnak | MediPurpose®
Agreement Continues U.K. Distribution of SurgiLance Safety Lancets, Now Also Includes babyLance Heel Sticks

By Derek Rudnak | MediPurpose®
The announcement comes one week after MediPurpose announced that inventory for MediPlus is now available for immediate distribution.

By Derek Rudnak | MediPurpose®
Qualified Submissions to Earn Entry for Amazon Kindle Drawing

By Derek Rudnak | MediPurpose®
The medical device company was recently notified that the Intellectual Property Office of Singapore approved MediPurpose’s application to register a trademark, collective mark or certification mark in Singapore for MediPlus.



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
8.4K1.9K2.6K
Click to Share